Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Liquidia Corporation (LQDA)
USD71.21
-6.72 (-8.62%)
US NASDAQ Healthcare Biotechnology
Address
419 Davis Drive 27560
Morrisville, NC, US
Morrisville, NC, US
CEO
Roger A. Jeffs
Website
liquidia.com
IPO
2018-07-26
CIK 1819576 ISIN US53635D2027
Description
Liquidia Corporation operates as a biopharmaceutical enterprise, concentrating on the development, production, and market introduction of various treatments aimed at fulfilling critical patient requirements throughout the United States. A key asset in its developmental portfolio is YUTREPIA, an innovative inhaled dry powder version of treprostinil, intended for managing pulmonary arterial hypertension. Beyond its pipeline, the company also distributes a generic treprostinil injection within the U.S. market. Founded in 2004, Liquidia Corporation's main office is located in Morrisville, North Carolina.
News Sentiment (7d)
Based on only 2 articles — low confidence
- LQDA Stock Soars 129.7% YTD: Is There More Room for Growth? Zacks Investment Research
Market Cap & Enterprise Value
Merger & Acquisition History
| Target company | Date | Filing |
|---|---|---|
| RareGen | 2020-08-04 | View |
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD71.21
-6.72 (-8.62%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
2M
Beta
0.59
Float Shares
62.26M
Free Float %
70.7%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +25.60% | +24.86% | +37.82% | +36.09% | +87.67% | +54.04% | +237.33% | +621.88% | +1,839.05% | +378.65% | +378.65% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (7 ratings, all time)
Buy
Price Targets & DCF
Current price
71.21
Low
60.00
-15.7%
Consensus
60.00
-15.7%
Median
60.00
-15.7%
High
60.00
-15.7%
Ratings Trend (MoM)
89% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 7 | 0 |
| Hold | 0 | 0 |
| Sell | 1 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 1 |
60.00
-15.7%
|
| Last Quarter | 1 |
60.00
-15.7%
|
| Last Year | 6 |
45.00
-36.8%
|
| All Time | 16 |
30.31
-57.4%
|
Quality scores
Altman Z-Score
6.99
Safe zone
Piotroski F-Score
7 / 9
Strong
MOAT Score
1 / 10
No MOAT
Composite Rating
B-
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
5 / 5
High
ROA Score
4 / 5
High
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%+1,031.2% ★ Q1'26: +4,158.5% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%+51.8% ★ Q1'26: +215.6% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-58.8% Q1'26: +37.8% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%-28.3% Q1'26: +46.3% (vs Q1'25)
-
ROIC Biotechnology: -16.1%-86.1% Q1'26: -401.6% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+9.3% Q1'26: +18.7% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-4.58× Q1'26: 0.23× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2018 actual |
Dec 2019 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 5 Rev. Ana. 6 EPS Ana. |
Dec 2027 5 Rev. Ana. 5 EPS Ana. |
Dec 2028 5 Rev. Ana. 5 EPS Ana. |
Dec 2029 2 Rev. Ana. 1 EPS Ana. |
Dec 2030 2 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
2.71M
est: 2.87M (-5.6%)
|
8.07M
est: 8.09M (-0.2%)
|
12.85M
est: 12.69M (+1.3%)
|
15.94M
est: 14.13M (+12.8%)
|
17.49M
est: 14.84M (+17.8%)
|
14.00M
est: 15.89M (-11.9%)
|
158.32M
est: 153.86M (+2.9%)
|
611.78M
540.71M – 688.92M
+297.6% YoY
|
1.04B
702.55M – 1.30B
+69.3% YoY
|
1.23B
1.23B – 1.23B
+19.0% YoY
|
1.42B
1.09B – 1.78B
+15.0% YoY
|
1.53B
1.18B – 1.92B
+7.9% YoY
|
| EBITDA |
-32.60M
est: -2.87M (-1,037.1%)
|
-43.42M
est: -8.09M (-436.9%)
|
-28.21M
est: -12.69M (-122.3%)
|
-35.03M
est: -29.46M (-18.9%)
|
-70.05M
est: -12.81M (-447.0%)
|
-115.71M
est: -13.71M (-743.7%)
|
-43.22M
est: -132.78M (+67.4%)
|
-527.95M
-594.52M – -466.62M
-297.6% YoY
|
-893.94M
-1.12B – -606.28M
-69.3% YoY
|
-1.06B
-1.06B – -1.06B
-19.0% YoY
|
-1.22B
-1.53B – -941.93M
-15.0% YoY
|
-1.32B
-1.65B – -1.02B
-7.9% YoY
|
| EBIT |
-34.15M
est: -2.87M (-1,090.9%)
|
-46.21M
est: -8.09M (-471.5%)
|
-33.82M
est: -12.69M (-166.5%)
|
-38.68M
est: -33.89M (-14.1%)
|
-72.23M
est: -12.84M (-462.7%)
|
-117.91M
est: -13.75M (-757.8%)
|
-44.75M
est: -133.07M (+66.4%)
|
-529.13M
-595.84M – -467.66M
-297.6% YoY
|
-895.94M
-1.13B – -607.63M
-69.3% YoY
|
-1.07B
-1.07B – -1.07B
-19.0% YoY
|
-1.23B
-1.54B – -944.04M
-15.0% YoY
|
-1.32B
-1.66B – -1.02B
-7.9% YoY
|
| Net Income |
-53.14M
est: -402.72M (+86.8%)
|
-47.58M
est: -203.59M (+76.6%)
|
-34.58M
est: -49.39M (+30.0%)
|
-41.02M
est: -50.89M (+19.4%)
|
-78.50M
est: -112.11M (+30.0%)
|
-130.39M
est: -132.63M (+1.7%)
|
-68.92M
est: -56.12M (-22.8%)
|
256.08M
23.81M – 365.07M
+556.3% YoY
|
530.14M
41.99M – 620.48M
+107.0% YoY
|
655.27M
390.78M – 769.50M
+23.6% YoY
|
634.43M
444.43M – 843.08M
-3.2% YoY
|
676.60M
473.97M – 899.11M
+6.6% YoY
|
| SGA |
8.75M
est: 28.23M (-69.0%)
|
13.60M
est: 79.60M (-82.9%)
|
23.11M
est: 124.93M (-81.5%)
|
32.41M
est: 139.12M (-76.7%)
|
44.74M
est: 39.21M (+14.1%)
|
81.57M
est: 41.99M (+94.3%)
|
157.18M
est: 406.54M (-61.3%)
|
1.62B
1.43B – 1.82B
+297.6% YoY
|
2.74B
1.86B – 3.44B
+69.3% YoY
|
3.26B
3.26B – 3.26B
+19.0% YoY
|
3.75B
2.88B – 4.70B
+15.0% YoY
|
4.04B
3.11B – 5.07B
+7.9% YoY
|
| EPS |
-7.42
est: -5.12 (-45.0%)
|
-2.51
est: -2.59 (+3.0%)
|
-0.70
est: -0.63 (-11.6%)
|
-0.67
est: -0.73 (+8.3%)
|
-1.21
est: -1.59 (+23.8%)
|
-1.66
est: -1.54 (-7.7%)
|
-0.80
est: -0.68 (-16.9%)
|
2.69
0.28 – 4.24
+493.1% YoY
|
5.26
0.49 – 7.21
+95.5% YoY
|
6.41
4.54 – 8.94
+21.8% YoY
|
7.37
5.16 – 9.80
+15.1% YoY
|
7.86
5.51 – 10.45
+6.6% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | B- | 2/5 | 1/5 | 5/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-08 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-15 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
106.05M
OE per share TTM
0.99
Owner's Yield
2.27%
Maintenance CapEx ratio
52.80%
Maint CapEx / Avg PPE
23.7%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
54
Total invested
66.54M
Insider transactions (90d)
7
Beneficial owners (>5%)
11
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Caligan Partners LP | 8.33M | 16.00% | — | 8.33M | — | 10.00 | IA, PN | Delaware | 2021-04-15 | ↗ |
| 2 | Legend Aggregator Advisors, LLC | 7.18M | 9.50% | — | 7.18M | — | 7.18M | OO | Delaware | 2024-01-16 | ↗ |
| 3 | Legend Aggregator, LP | 7.18M | 9.50% | — | 7.18M | — | 7.18M | PN | Delaware | 2024-01-16 | ↗ |
| 4 | Paul B. Manning | 5.18M | 10.00% | 4.50M | 677.6K | 4.50M | 677.6K | IN | Delaware | 2022-02-14 | ↗ |
| 5 | (1) BlackRock, Inc. | 4.21M | 5.00% | 4.10M | — | — | — | HC | Delaware | 2024-11-08 | ↗ |
| 6 | PBM Capital Finance, LLC | 3.92M | 9.00% | 3.92M | — | 3.92M | — | OO | Delaware | 2021-02-16 | ↗ |
| 7 | Eshelman | 2.60M | 6.00% | 2.60M | — | 2.60M | — | IN | North Carolina | 2021-01-28 | ↗ |
| 8 | LLC | 2.43M | 5.60% | 2.43M | — | 2.43M | — | OO | North Carolina | 2021-01-28 | ↗ |
| 9 | BKB Growth Investments, LLC | 479.2K | 0.90% | 479.2K | — | 479.2K | — | OO | Delaware | 2022-02-14 | ↗ |
| 10 | PD Joint Holdings, LLC, Series 2016-A | 198.4K | 0.40% | 198.4K | — | 198.4K | — | OO | United States | 2022-02-14 | ↗ |
| 11 | David Johnson | 46.1K | 16.10% | 46.1K | 8.33M | 46.1K | 10.00 | IN | United States | 2021-04-15 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
54
-203 vs prev Q
New positions
14
Closed positions
190
Increased
24
Reduced
21
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | — | 587.2K +587.2K (+100.0%) | 20.25B +20.3B (+100.0%) | 0.68% +0.680 pp | 14.25% +14.253 pp | USD34.49 +0.0% | 1 qtrs NEW |
| 2 | FARALLON CAPITAL MANAGEMENT LLC | 8.66M +90.4K (+1.1%) | 298.55M +103.8M (+53.3%) | 10.03% +0.018 pp | 1.41% +0.611 pp | USD18.25 +89.0% | 8 qtrs — |
| 3 | CALIGAN PARTNERS LP | 8.12M +— (+0.0%) | 280.02M +95.4M (+51.7%) | 9.40% -0.082 pp | 23.05% -1.130 pp | USD6.98 +394.1% | 13 qtrs — |
| 4 | BLACKROCK, INC. | 5.49M +259.6K (+5.0%) | 189.29M +70.4M (+59.2%) | 6.36% +0.248 pp | 0.00% +0.001 pp | USD12.22 +182.2% | 6 qtrs — |
| 5 | VANGUARD GROUP INC | 4.01M +52.7K (+1.3%) | 138.44M +48.4M (+53.7%) | 4.65% +0.021 pp | 0.00% +0.001 pp | USD9.91 +248.0% | 30 qtrs — |
| 6 | FINDELL CAPITAL MANAGEMENT LLC | 2.85M +21.4K (+0.8%) | 98.35M +34.0M (+52.8%) | 3.30% -0.004 pp | 28.28% +2.880 pp | USD11.75 +193.5% | 9 qtrs — |
| 7 | OPALEYE MANAGEMENT INC. | 2.44M -180.0K (-6.9%) | 84.98M +25.5M (+42.9%) | 2.82% -0.235 pp | 11.21% +2.804 pp | USD11.32 +204.7% | 17 qtrs — |
| 8 | BANK OF AMERICA CORP /DE/ | 1.93M +1.2M (+151.8%) | 66.48M +49.1M (+282.0%) | 2.23% +1.338 pp | 0.00% +0.004 pp | USD28.93 +19.2% | 30 qtrs — |
| 9 | STATE STREET CORP | 1.81M -105.0K (-5.5%) | 62.39M +18.9M (+43.4%) | 2.10% -0.141 pp | 0.00% +0.001 pp | USD10.20 +238.1% | 30 qtrs — |
| 10 | CAPROCK GROUP, LLC | 1.78M +151.8K (+9.3%) | 61.53M +16.4M (+36.2%) | 2.07% +0.159 pp | 1.30% +0.187 pp | USD23.74 +45.3% | 2 qtrs — |
| 11 | TCG CROSSOVER MANAGEMENT, LLC | 1.71M +— (+0.0%) | 58.98M +20.1M (+51.7%) | 1.98% -0.017 pp | 1.95% +0.039 pp | USD22.74 +51.7% | 2 qtrs — |
| 12 | D. E. SHAW & CO., INC. | 1.67M +179.5K (+12.1%) | 57.51M +23.7M (+70.0%) | 1.93% +0.193 pp | 0.03% +0.012 pp | USD23.28 +48.2% | 11 qtrs — |
| 13 | GEODE CAPITAL MANAGEMENT, LLC | 1.62M +13.2K (+0.8%) | 55.91M +19.3M (+52.9%) | 1.88% -0.001 pp | 0.00% +0.001 pp | USD10.08 +242.2% | 30 qtrs — |
| 14 | BIOIMPACT CAPITAL LLC | 1.40M +1.2M (+600.4%) | 48.32M +43.8M (+962.4%) | 1.62% +1.389 pp | 5.53% +4.784 pp | USD32.81 +5.1% | 2 qtrs — |
| 15 | CAPTION MANAGEMENT, LLC | 1.05M +92.0K (+9.6%) | 36.35M +14.5M (+66.2%) | 1.22% +0.097 pp | 0.25% +0.079 pp | USD22.22 +55.2% | 3 qtrs — |
| 16 | CITADEL ADVISORS LLC | 800.2K +350.6K (+78.0%) | 27.60M +17.4M (+170.0%) | 0.93% +0.402 pp | 0.00% +0.003 pp | USD22.87 +50.8% | 28 qtrs — |
| 17 | GOLDMAN SACHS GROUP INC | 704.1K -2.1M (-74.7%) | 24.28M -39.0M (-61.6%) | 0.82% -2.435 pp | 0.00% -0.005 pp | USD13.53 +154.9% | 20 qtrs — |
| 18 | BOOTHBAY FUND MANAGEMENT, LLC | 613.5K -82.6K (-11.9%) | 21.16M +5.3M (+33.7%) | 0.71% -0.103 pp | 0.32% +0.086 pp | USD13.01 +165.1% | 9 qtrs — |
| 19 | WHITEFORT CAPITAL MANAGEMENT, LP | 594.7K +594.7K (+100.0%) | 20.51M +20.5M (+100.0%) | 0.69% +0.689 pp | 5.24% +5.244 pp | USD34.49 +0.0% | 1 qtrs NEW |
| 20 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 561.7K -860.0 (-0.2%) | 19.37M +6.6M (+51.4%) | 0.65% -0.007 pp | 0.00% +0.001 pp | USD12.14 +184.1% | 30 qtrs — |
| 21 | NORTHERN TRUST CORP | 560.8K -36.1K (-6.0%) | 19.34M +5.8M (+42.5%) | 0.65% -0.048 pp | 0.00% +0.001 pp | USD7.81 +341.6% | 30 qtrs — |
| 22 | VOLORIDGE INVESTMENT MANAGEMENT, LLC | 532.4K -20.4K (-3.7%) | 18.36M +5.8M (+46.1%) | 0.62% -0.029 pp | 0.06% +0.022 pp | USD22.74 +51.7% | 2 qtrs — |
| 23 | EVERSEPT PARTNERS, LP | 509.4K +23.4K (+4.8%) | 17.57M +6.5M (+59.0%) | 0.59% +0.022 pp | 0.89% +0.124 pp | USD15.37 +124.4% | 25 qtrs — |
| 24 | POINT72 ASSET MANAGEMENT, L.P. | 500.0K -1.5M (-75.0%) | 17.25M -28.2M (-62.1%) | 0.58% -1.758 pp | 0.02% -0.057 pp | USD22.74 +51.7% | 2 qtrs — |
| 25 | FEDERATED HERMES, INC. | 486.3K +165.7K (+51.7%) | 16.77M +9.5M (+130.1%) | 0.56% +0.189 pp | 0.03% +0.015 pp | USD26.74 +29.0% | 2 qtrs — |
| 26 | MORGAN STANLEY | 473.5K -533.2K (-53.0%) | 16.33M -6.6M (-28.7%) | 0.55% -0.628 pp | 0.00% 0.000 pp | USD18.11 +90.4% | 30 qtrs — |
| 27 | PRUDENTIAL FINANCIAL INC | 459.8K +436.2K (+1,851.9%) | 15.86M +15.3M (+2,860.4%) | 0.53% +0.505 pp | 0.02% +0.019 pp | USD33.89 +1.8% | 2 qtrs — |
| 28 | INVESCO LTD. | 420.6K +341.0K (+428.3%) | 14.51M +12.7M (+701.3%) | 0.49% +0.394 pp | 0.00% +0.002 pp | USD31.37 +9.9% | 16 qtrs — |
| 29 | JANE STREET GROUP, LLC | 417.6K -355.7K (-46.0%) | 14.40M -3.2M (-18.1%) | 0.48% -0.420 pp | 0.00% -0.001 pp | USD22.11 +56.0% | 16 qtrs — |
| 30 | PALE FIRE CAPITAL SE | 379.4K +138.7K (+57.6%) | 13.09M +7.6M (+139.0%) | 0.44% +0.158 pp | 0.88% +0.279 pp | USD24.71 +39.6% | 3 qtrs — |
| 31 | FMR LLC | 378.3K -529.3K (-58.3%) | 13.05M -7.6M (-36.8%) | 0.44% -0.622 pp | 0.00% 0.000 pp | USD14.68 +134.9% | 15 qtrs — |
| 32 | APIS CAPITAL ADVISORS, LLC | 355.2K -65.6K (-15.6%) | 12.25M +2.7M (+28.0%) | 0.41% -0.080 pp | 2.13% +0.021 pp | USD22.74 +51.7% | 2 qtrs — |
| 33 | TWO SIGMA INVESTMENTS, LP | 350.0K -84.1K (-19.4%) | 12.07M +2.2M (+22.3%) | 0.41% -0.102 pp | 0.02% +0.002 pp | USD10.48 +229.1% | 19 qtrs — |
| 34 | OBERWEIS ASSET MANAGEMENT INC/ | 329.2K +8.0K (+2.5%) | 11.35M +4.1M (+55.4%) | 0.38% +0.006 pp | 0.42% +0.136 pp | USD13.57 +154.2% | 8 qtrs — |
| 35 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 308.7K -264.7K (-46.2%) | 10.65M -2.4M (-18.3%) | 0.36% -0.312 pp | 0.00% 0.000 pp | USD19.48 +77.1% | 22 qtrs — |
| 36 | FIRST TRUST ADVISORS LP | 307.0K +307.0K (+100.0%) | 10.59M +10.6M (+100.0%) | 0.36% +0.356 pp | 0.01% +0.008 pp | USD34.49 +0.0% | 3 qtrs — |
| 37 | TREXQUANT INVESTMENT LP | 279.1K -126.5K (-31.2%) | 9.63M +402.9K (+4.4%) | 0.32% -0.151 pp | 0.09% -0.009 pp | USD22.74 +51.7% | 2 qtrs — |
| 38 | TUDOR INVESTMENT CORP ET AL | 263.7K +263.7K (+100.0%) | 9.10M +9.1M (+100.0%) | 0.31% +0.305 pp | 0.02% +0.017 pp | USD34.49 +0.0% | 1 qtrs NEW |
| 39 | MIRABELLA FINANCIAL SERVICES LLP | 247.8K +394.0 (+0.2%) | 8.55M +2.9M (+51.9%) | 0.29% -0.002 pp | 0.80% +0.319 pp | USD11.80 +192.3% | 5 qtrs — |
| 40 | BARCLAYS PLC | 236.3K -125.0K (-34.6%) | 8.15M -66.0K (-0.8%) | 0.27% -0.148 pp | 0.00% 0.000 pp | USD22.12 +55.9% | 3 qtrs — |
| 41 | WELLINGTON MANAGEMENT GROUP LLP | 233.1K -6.4K (-2.7%) | 8.04M +2.6M (+47.6%) | 0.27% -0.010 pp | 0.00% +0.001 pp | USD14.63 +135.7% | 9 qtrs — |
| 42 | PATIENT SQUARE CAPITAL LP | 227.0K -173.0K (-43.3%) | 7.83M -1.3M (-13.9%) | 0.26% -0.204 pp | 1.68% -0.757 pp | USD14.92 +131.2% | 8 qtrs — |
| 43 | RENAISSANCE TECHNOLOGIES LLC | 206.9K -277.9K (-57.3%) | 7.13M -3.9M (-35.3%) | 0.24% -0.327 pp | 0.01% -0.004 pp | USD22.74 +51.7% | 5 qtrs — |
| 44 | BANK OF NEW YORK MELLON CORP | 198.7K -11.4K (-5.4%) | 6.85M +2.1M (+43.4%) | 0.23% -0.015 pp | 0.00% +0.000 pp | USD7.24 +376.4% | 29 qtrs — |
| 45 | DEUTSCHE BANK AG\ | 187.8K +141.5K (+305.1%) | 6.48M +5.4M (+514.4%) | 0.22% +0.163 pp | 0.00% +0.002 pp | USD28.53 +20.9% | 15 qtrs — |
| 46 | HRT FINANCIAL LP | 168.2K +168.2K (+100.0%) | 5.80M +5.8M (+100.0%) | 0.19% +0.195 pp | 0.02% +0.018 pp | USD34.49 +0.0% | 3 qtrs — |
| 47 | BANCO BILBAO VIZCAYA ARGENTARIA, S.A. | 157.2K -8.6K (-5.2%) | 5.38M +1.6M (+42.0%) | 0.18% -0.012 pp | 0.04% +0.009 pp | USD12.86 +168.2% | 6 qtrs — |
| 48 | HIGHVISTA STRATEGIES LLC | 156.0K -20.5K (-11.6%) | 5.38M +1.4M (+34.1%) | 0.18% -0.026 pp | 1.39% +0.402 pp | USD15.00 +129.9% | 7 qtrs — |
| 49 | WALLEYE CAPITAL LLC | 155.3K +1.5K (+1.0%) | 5.36M +1.9M (+53.2%) | 0.18% +0.000 pp | 0.02% +0.003 pp | USD16.27 +112.0% | 19 qtrs — |
| 50 | CAXTON ASSOCIATES LLP | 155.0K +137.9K (+805.4%) | 5.35M +5.0M (+1,273.2%) | 0.18% +0.160 pp | 0.10% +0.096 pp | USD33.19 +3.9% | 2 qtrs — |
| 51 | NUVEEN, LLC | 151.2K -3.5K (-2.2%) | 5.21M +1.7M (+48.3%) | 0.18% -0.006 pp | 0.00% +0.000 pp | USD14.75 +133.8% | 4 qtrs — |
| 52 | UBS ASSET MANAGEMENT AMERICAS INC | 147.3K -6.1K (-4.0%) | 5.08M +1.6M (+45.7%) | 0.17% -0.009 pp | 0.00% +0.000 pp | USD19.57 +76.2% | 8 qtrs — |
| 53 | CITIGROUP INC | 146.6K +64.2K (+78.0%) | 5.06M +3.2M (+169.9%) | 0.17% +0.074 pp | 0.00% +0.001 pp | USD24.84 +38.8% | 16 qtrs — |
| 54 | MARSHALL WACE, LLP | 145.6K -186.7K (-56.2%) | 5.02M -2.5M (-33.5%) | 0.17% -0.220 pp | 0.00% -0.003 pp | USD12.35 +179.3% | 7 qtrs — |
| 55 | INSIGHT WEALTH STRATEGIES, LLC | 141.8K +141.8K (+100.0%) | 4.89M +4.9M (+100.0%) | 0.16% +0.164 pp | 0.56% +0.561 pp | USD34.49 +0.0% | 1 qtrs NEW |
| 56 | GREENLAND CAPITAL MANAGEMENT LP | 131.5K -58.2K (-30.7%) | 4.54M +221.0K (+5.1%) | 0.15% -0.069 pp | 0.48% +0.049 pp | USD18.65 +84.9% | 5 qtrs — |
| 57 | CENTERBOOK PARTNERS LP | 125.0K -359.9K (-74.2%) | 4.31M -6.7M (-60.9%) | 0.14% -0.422 pp | 0.21% -0.334 pp | USD12.71 +171.4% | 4 qtrs — |
| 58 | JPMORGAN CHASE & CO | 121.7K +93.7K (+335.7%) | 4.20M +3.6M (+560.9%) | 0.14% +0.108 pp | 0.00% +0.000 pp | USD29.43 +17.2% | 15 qtrs — |
| 59 | TWO SIGMA ADVISERS, LP | 121.4K -108.0K (-47.1%) | 4.19M -1.0M (-19.7%) | 0.14% -0.127 pp | 0.01% -0.002 pp | USD9.12 +278.2% | 17 qtrs — |
| 60 | SWISS NATIONAL BANK | 118.8K -5.4K (-4.3%) | 4.10M +1.3M (+45.1%) | 0.14% -0.008 pp | 0.00% +0.001 pp | USD14.00 +146.4% | 8 qtrs — |
| 61 | Y-INTERCEPT (HONG KONG) LTD | 116.9K +91.3K (+357.0%) | 4.03M +3.5M (+593.2%) | 0.14% +0.106 pp | 0.09% +0.076 pp | USD29.67 +16.2% | 3 qtrs — |
| 62 | ALGERT GLOBAL LLC | 112.4K +112.4K (+100.0%) | 3.88M +3.9M (+100.0%) | 0.13% +0.130 pp | 0.06% +0.060 pp | USD34.49 +0.0% | 1 qtrs NEW |
| 63 | UBS GROUP AG | 111.8K -300.6K (-72.9%) | 3.85M -5.5M (-58.9%) | 0.13% -0.352 pp | 0.00% -0.001 pp | USD15.49 +122.7% | 30 qtrs — |
| 64 | MILLENNIUM MANAGEMENT LLC | 105.6K -869.1K (-89.2%) | 3.64M -18.5M (-83.6%) | 0.12% -1.017 pp | 0.00% -0.008 pp | USD22.55 +52.9% | 12 qtrs — |
| 65 | ENGINEERS GATE MANAGER LP | 101.8K +86.3K (+554.4%) | 3.51M +3.2M (+892.5%) | 0.12% +0.100 pp | 0.04% +0.038 pp | USD32.69 +5.5% | 2 qtrs — |
| 66 | WOODLINE PARTNERS LP | 100.2K +— (+0.0%) | 3.45M +1.2M (+51.7%) | 0.12% -0.001 pp | 0.01% +0.003 pp | USD10.64 +224.2% | 6 qtrs — |
| 67 | JW ASSET MANAGEMENT, LLC | 99.8K -10.2K (-9.3%) | 3.44M +939.9K (+37.6%) | 0.12% -0.013 pp | 1.12% -0.080 pp | USD22.74 +51.7% | 2 qtrs — |
| 68 | AWH CAPITAL, L.P. | 92.5K +7.5K (+8.8%) | 3.19M +1.3M (+65.1%) | 0.11% +0.008 pp | 2.94% +0.927 pp | USD15.97 +116.0% | 3 qtrs — |
| 69 | DIAMETRIC CAPITAL, LP | 91.5K -18.0K (-16.5%) | 3.16M +664.6K (+26.7%) | 0.11% -0.022 pp | 0.85% -0.078 pp | USD10.68 +222.9% | 16 qtrs — |
| 70 | EXOME ASSET MANAGEMENT LLC | 91.1K -3.1K (-3.3%) | 3.14M +1.0M (+46.7%) | 0.11% -0.005 pp | 1.50% +0.206 pp | USD20.50 +68.2% | 3 qtrs — |
| 71 | OCCUDO QUANTITATIVE STRATEGIES LP | 90.1K +90.1K (+100.0%) | 3.11M +3.1M (+100.0%) | 0.10% +0.104 pp | 0.21% +0.208 pp | USD34.49 +0.0% | 1 qtrs NEW |
| 72 | LEGAL & GENERAL GROUP PLC | 85.6K -8.5K (-9.0%) | 2.95M +814.0K (+38.0%) | 0.10% -0.011 pp | 0.00% +0.000 pp | USD13.60 +153.6% | 15 qtrs — |
| 73 | RAYMOND JAMES FINANCIAL INC | 84.4K +45.4K (+116.1%) | 2.91M +2.0M (+227.8%) | 0.10% +0.052 pp | 0.00% +0.001 pp | USD25.04 +37.7% | 5 qtrs — |
| 74 | AMERIPRISE FINANCIAL INC | 81.3K +70.4K (+651.6%) | 2.80M +2.6M (+1,040.0%) | 0.09% +0.082 pp | 0.00% +0.001 pp | USD32.93 +4.7% | 4 qtrs — |
| 75 | RHUMBLINE ADVISERS | 78.5K -12.9K (-14.1%) | 2.71M +630.0K (+30.3%) | 0.09% -0.016 pp | 0.00% +0.001 pp | USD6.80 +407.2% | 15 qtrs — |
| 76 | ADVISOR GROUP HOLDINGS, INC. | 77.4K +75.4K (+3,721.4%) | 2.67M +2.6M (+5,615.1%) | 0.09% +0.087 pp | 0.00% +0.004 pp | USD34.05 +1.3% | 19 qtrs — |
| 77 | VERITION FUND MANAGEMENT LLC | 75.0K +75.0K (+100.0%) | 2.59M +2.6M (+100.0%) | 0.09% +0.087 pp | 0.01% +0.010 pp | USD34.49 +0.0% | 1 qtrs NEW |
| 78 | WELLS FARGO & COMPANY/MN | 75.0K +33.7K (+81.5%) | 2.59M +1.6M (+175.3%) | 0.09% +0.039 pp | 0.00% +0.000 pp | USD21.78 +58.4% | 30 qtrs — |
| 79 | RUSSELL INVESTMENTS GROUP, LTD. | 74.8K +100.0 (+0.1%) | 2.58M +880.9K (+51.9%) | 0.09% -0.001 pp | 0.00% +0.001 pp | USD8.30 +315.5% | 14 qtrs — |
| 80 | ADVISORY SERVICES NETWORK, LLC | 72.7K +3.6K (+5.2%) | 2.51M +935.3K (+59.5%) | 0.08% +0.004 pp | 0.04% +0.012 pp | USD10.44 +230.4% | 15 qtrs — |
| 81 | ALLIANCEBERNSTEIN L.P. | 68.7K +1.6K (+2.4%) | 2.37M +843.0K (+55.3%) | 0.08% +0.001 pp | 0.00% +0.000 pp | USD7.64 +351.4% | 15 qtrs — |
| 82 | SQUAREPOINT OPS LLC | 67.9K +67.9K (+100.0%) | 2.34M +2.3M (+100.0%) | 0.08% +0.079 pp | 0.00% +0.003 pp | USD34.49 +0.0% | 11 qtrs — |
| 83 | SCHONFELD STRATEGIC ADVISORS LLC | 65.7K +65.7K (+100.0%) | 2.27M +2.3M (+100.0%) | 0.08% +0.076 pp | 0.01% +0.010 pp | USD34.49 +0.0% | 1 qtrs NEW |
Ownership breakdown by holder
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.48
Bearish
Ratio by volume
0.36
Bearish
Buys
23
Sells
48
Shares acquired
330.9K
Shares disposed
919.8K
Cash buys
—
Cash sales
25.00
Net activity
-588,912
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-07 | JEFFS ROGER | Director / Officer | S-Sale | D | Common Stock | 25,000 | 42.09 | 1.05M | 1,348,095 | I | ↗ |
| 2026-05-06 | JEFFS ROGER | Director / Officer | S-Sale | D | Common Stock | 25,000 | 40.78 | 1.02M | 1,373,095 | I | ↗ |
| 2026-05-05 | JEFFS ROGER | Director / Officer | S-Sale | D | Common Stock | 25,000 | 40.10 | 1.00M | 1,398,095 | I | ↗ |
| 2026-04-27 | Boyle Dana | Officer | S-Sale | D | Common Stock | 1,576 | 37.78 | 59.5K | 175,342 | D | ↗ |
| 2026-04-27 | Adair Jason | Officer | S-Sale | D | Common Stock | 688 | 41.65 | 28.7K | 214,738 | D | ↗ |
| 2026-04-17 | JEFFS ROGER | Director / Officer | S-Sale | D | Common Stock | 18,839 | 40.60 | 765.0K | 1,423,095 | I | ↗ |
| 2026-04-16 | JEFFS ROGER | Director / Officer | S-Sale | D | Common Stock | 25,000 | 40.31 | 1.01M | 1,441,934 | I | ↗ |
| 2026-04-15 | Kaseta Michael | Officer | S-Sale | D | Common Stock | 86,971 | 40.14 | 3.49M | 396,731 | D | ↗ |
| 2026-04-15 | JEFFS ROGER | Director / Officer | S-Sale | D | Common Stock | 25,000 | 40.14 | 1.00M | 1,466,934 | I | ↗ |
| 2026-04-14 | Kaseta Michael | Officer | M-Exempt | D | Incentive Stock Option (right to buy) | 3,000 | 2.79 | 8.4K | 97,505 | D | ↗ |
| 2026-04-14 | JEFFS ROGER | Director / Officer | S-Sale | D | Common Stock | 3,300 | 40.00 | 132.0K | 1,491,934 | I | ↗ |
| 2026-04-13 | Schundler Russell | Officer | S-Sale | D | Common Stock | 13,692 | 38.37 | 525.4K | 610,532 | D | ↗ |
| 2026-04-13 | Saggar Rajeev | Officer | S-Sale | D | Common Stock | 9,220 | 38.37 | 353.8K | 173,270 | D | ↗ |
| 2026-04-13 | Moomaw Scott | Officer | S-Sale | D | Common Stock | 1,686 | 38.20 | 64.4K | 184,558 | D | ↗ |
| 2026-04-13 | Krepp Sarah | Officer | S-Sale | D | Common Stock | 4,557 | 38.37 | 174.9K | 147,019 | D | ↗ |
| 2026-04-13 | Kaseta Michael | Officer | S-Sale | D | Common Stock | 18,958 | 38.37 | 727.4K | 405,775 | D | ↗ |
| 2026-04-13 | JEFFS ROGER | Director / Officer | S-Sale | D | Common Stock | 32,744 | 38.37 | 1.26M | 1,137,599 | D | ↗ |
| 2026-04-13 | Boyle Dana | Officer | S-Sale | D | Common Stock | 5,101 | 38.37 | 195.7K | 176,918 | D | ↗ |
| 2026-04-13 | Adair Jason | Officer | S-Sale | D | Common Stock | 7,301 | 38.37 | 280.1K | 215,426 | D | ↗ |
| 2026-04-10 | Schundler Russell | Officer | M-Exempt | D | Performance Stock Units | 3,758 | 0.00 | — | 26,309 | D | ↗ |
| 2026-04-10 | Saggar Rajeev | Officer | M-Exempt | D | Performance Stock Units | 4,486 | 0.00 | — | 49,349 | D | ↗ |
| 2026-04-10 | Moomaw Scott | Officer | M-Exempt | A | Common Stock | 4,358 | 0.00 | — | 195,105 | D | ↗ |
| 2026-04-10 | Krepp Sarah | Officer | M-Exempt | D | Performance Stock Units | 3,179 | 0.00 | — | 34,966 | D | ↗ |
| 2026-04-10 | Kaseta Michael | Officer | M-Exempt | D | Performance Stock Units | 5,828 | 0.00 | — | 40,797 | D | ↗ |
| 2026-04-10 | JEFFS ROGER | Director / Officer | S-Sale | D | Common Stock | 21,433 | 40.12 | 859.9K | 1,495,234 | I | ↗ |
| 2026-04-10 | Boyle Dana | Officer | M-Exempt | A | Common Stock | 3,179 | 0.00 | — | 182,019 | D | ↗ |
| 2026-04-10 | Adair Jason | Officer | M-Exempt | D | Performance Stock Units | 3,868 | 0.00 | — | 42,553 | D | ↗ |
| 2026-04-09 | Kaseta Michael | Officer | S-Sale | D | Common Stock | 133,789 | 40.24 | 5.38M | 411,855 | D | ↗ |
| 2026-04-09 | JEFFS ROGER | Director / Officer | S-Sale | D | Common Stock | 25,000 | 40.12 | 1.00M | 1,516,667 | I | ↗ |
| 2026-03-27 | Bloch Stephen M | Director | S-Sale | D | Common Stock | 30,401 | 35.42 | 1.08M | 2,221,084 | I | ↗ |
| 2026-03-26 | Bloch Stephen M | Director | S-Sale | D | Common Stock | 7,684 | 37.22 | 286.0K | 2,251,485 | I | ↗ |
| 2026-03-23 | Moomaw Scott | Officer | S-Sale | D | Common Stock | 17,000 | 36.81 | 625.8K | 187,640 | D | ↗ |
| 2026-03-13 | Saggar Rajeev | Officer | S-Sale | D | Common Stock | 35,365 | 36.30 | 1.28M | 174,473 | D | ↗ |
| 2026-03-13 | SINGH RAMAN | Director | M-Exempt | A | Common Stock | 20,000 | 4.86 | 97.2K | 58,755 | D | ↗ |
| 2026-03-13 | Krepp Sarah | Officer | S-Sale | D | Common Stock | 16,261 | 38.00 | 617.9K | 148,397 | D | ↗ |
| 2026-03-09 | Moomaw Scott | Officer | S-Sale | D | Common Stock | 80,000 | 35.32 | 2.83M | 188,954 | D | ↗ |
| 2026-03-02 | Schundler Russell | Officer | S-Sale | D | Common Stock | 1,073 | 30.58 | 32.8K | 614,057 | D | ↗ |
| 2026-03-02 | Moomaw Scott | Officer | S-Sale | D | Common Stock | 827 | 30.58 | 25.3K | 188,954 | D | ↗ |
| 2026-03-02 | Krepp Sarah | Officer | S-Sale | D | Common Stock | 276 | 30.58 | 8.4K | 164,658 | D | ↗ |
| 2026-03-02 | Kaseta Michael | Officer | S-Sale | D | Common Stock | 1,165 | 30.58 | 35.6K | 411,855 | D | ↗ |
| 2026-03-02 | Boyle Dana | Officer | S-Sale | D | Common Stock | 445 | 30.58 | 13.6K | 178,840 | D | ↗ |
| 2026-03-02 | Adair Jason | Officer | S-Sale | D | Common Stock | 689 | 30.58 | 21.1K | 212,479 | D | ↗ |
| 2026-02-27 | Schundler Russell | Officer | M-Exempt | D | Restricted Stock Units | 2,344 | 0.00 | — | 0 | D | ↗ |
| 2026-02-27 | Moomaw Scott | Officer | M-Exempt | A | Common Stock | 1,875 | 0.00 | — | 189,781 | D | ↗ |
| 2026-02-27 | Kaseta Michael | Officer | M-Exempt | A | Common Stock | 2,344 | 0.00 | — | 413,020 | D | ↗ |
| 2026-02-27 | Adair Jason | Officer | M-Exempt | A | Common Stock | 1,562 | 0.00 | — | 213,168 | D | ↗ |
| 2026-02-11 | Manning Paul B | Director | J-Other | A | Common Stock | 55,116 | 42.63 | 2.35M | 469,583 | D | ↗ |
| 2026-01-26 | Boyle Dana | Officer | S-Sale | D | Common Stock | 1,580 | 41.65 | 65.8K | 178,848 | D | ↗ |
| 2026-01-26 | Adair Jason | Officer | S-Sale | D | Common Stock | 688 | 41.65 | 28.7K | 211,169 | D | ↗ |
| 2026-01-16 | Schundler Russell | Officer | A-Award | A | Performance Stock Units | 49,433 | 0.00 | — | 49,433 | D | ↗ |
| 2026-01-16 | Saggar Rajeev | Officer | A-Award | A | Performance Stock Units | 49,433 | 0.00 | — | 49,433 | D | ↗ |
| 2026-01-16 | Moomaw Scott | Officer | A-Award | A | Performance Stock Units | 49,433 | 0.00 | — | 49,433 | D | ↗ |
| 2026-01-16 | Krepp Sarah | Officer | A-Award | A | Performance Stock Units | 35,592 | 0.00 | — | 35,592 | D | ↗ |
| 2026-01-16 | Khindri Sanjeev | Officer | A-Award | A | Common Stock | 34,274 | 0.00 | — | 71,266 | D | ↗ |
| 2026-01-16 | Kaseta Michael | Officer | A-Award | A | Performance Stock Units | 88,980 | 0.00 | — | 88,980 | D | ↗ |
| 2026-01-16 | JEFFS ROGER | Director / Officer | A-Award | A | Common Stock | 115,344 | 0.00 | — | 1,152,872 | D | ↗ |
| 2026-01-16 | Boyle Dana | Officer | A-Award | A | Performance Stock Units | 35,592 | 0.00 | — | 35,592 | D | ↗ |
| 2026-01-16 | Adair Jason | Officer | A-Award | A | Performance Stock Units | 41,525 | 0.00 | — | 41,525 | D | ↗ |
| 2026-01-12 | Schundler Russell | Officer | S-Sale | D | Common Stock | 27,289 | 37.43 | 1.02M | 579,394 | D | ↗ |
| 2026-01-12 | Saggar Rajeev | Officer | S-Sale | D | Common Stock | 21,142 | 37.43 | 791.3K | 176,883 | D | ↗ |
| 2026-01-12 | Moomaw Scott | Officer | S-Sale | D | Common Stock | 20,533 | 37.43 | 768.6K | 154,514 | D | ↗ |
| 2026-01-12 | Krepp Sarah | Officer | S-Sale | D | Common Stock | 13,165 | 37.43 | 492.8K | 140,769 | D | ↗ |
| 2026-01-12 | Kaseta Michael | Officer | S-Sale | D | Common Stock | 36,932 | 37.43 | 1.38M | 350,919 | D | ↗ |
| 2026-01-12 | JEFFS ROGER | Director / Officer | S-Sale | D | Common Stock | 66,610 | 37.43 | 2.49M | 1,037,528 | D | ↗ |
| 2026-01-12 | Boyle Dana | Officer | S-Sale | D | Common Stock | 11,047 | 37.43 | 413.5K | 156,700 | D | ↗ |
| 2026-01-12 | Adair Jason | Officer | S-Sale | D | Common Stock | 13,548 | 37.43 | 507.1K | 184,174 | D | ↗ |
| 2026-01-09 | Schundler Russell | Officer | M-Exempt | A | Common Stock | 3,759 | 0.00 | — | 581,047 | D | ↗ |
| 2026-01-09 | Saggar Rajeev | Officer | M-Exempt | A | Common Stock | 3,531 | 0.00 | — | 180,080 | D | ↗ |
| 2026-01-09 | Moomaw Scott | Officer | M-Exempt | A | Common Stock | 17,433 | 0.00 | — | 175,047 | D | ↗ |
| 2026-01-09 | Krepp Sarah | Officer | M-Exempt | A | Common Stock | 12,716 | 0.00 | — | 153,934 | D | ↗ |
| 2026-01-09 | Kaseta Michael | Officer | M-Exempt | A | Common Stock | 28,200 | 0.00 | — | 387,851 | D | ↗ |
| 2026-01-09 | JEFFS ROGER | Director / Officer | M-Exempt | D | Performance Stock Units | 13,833 | 0.00 | — | 110,669 | D | ↗ |
| 2026-01-09 | Boyle Dana | Officer | M-Exempt | D | Performance Stock Units | 12,716 | 0.00 | — | 38,145 | D | ↗ |
| 2026-01-09 | Adair Jason | Officer | M-Exempt | A | Common Stock | 3,906 | 0.00 | — | 179,774 | D | ↗ |
| 2026-01-01 | Khindri Sanjeev | Officer | — | — | Common Stock | 0 | 0.00 | — | 36,992 | D | ↗ |
| 2025-12-01 | Schundler Russell | Officer | S-Sale | D | Common Stock | 1,072 | 32.19 | 34.5K | 577,288 | D | ↗ |
| 2025-12-01 | Moomaw Scott | Officer | S-Sale | D | Common Stock | 831 | 32.19 | 26.7K | 154,506 | D | ↗ |
| 2025-12-01 | Krepp Sarah | Officer | S-Sale | D | Common Stock | 221 | 32.19 | 7.1K | 141,218 | D | ↗ |
| 2025-12-01 | Kaseta Michael | Officer | S-Sale | D | Common Stock | 1,166 | 32.19 | 37.5K | 353,823 | D | ↗ |
| 2025-12-01 | Boyle Dana | Officer | S-Sale | D | Common Stock | 303 | 32.19 | 9.8K | 155,031 | D | ↗ |
| 2025-12-01 | Adair Jason | Officer | S-Sale | D | Common Stock | 693 | 32.19 | 22.3K | 175,868 | D | ↗ |
| 2025-11-28 | Schundler Russell | Officer | M-Exempt | D | Restricted Stock Units | 2,343 | 0.00 | — | 2,344 | D | ↗ |
| 2025-11-28 | Moomaw Scott | Officer | M-Exempt | D | Restricted Stock Units | 1,875 | 0.00 | — | 1,875 | D | ↗ |
| 2025-11-28 | Kaseta Michael | Officer | M-Exempt | A | Common Stock | 2,343 | 0.00 | — | 354,989 | D | ↗ |
| 2025-11-28 | Adair Jason | Officer | M-Exempt | D | Restricted Stock Units | 1,563 | 0.00 | — | 1,562 | D | ↗ |
| 2025-11-18 | Adair Jason | Officer | M-Exempt | A | Common Stock | 365 | 5.89 | 2.1K | 210,654 | D | ↗ |
| 2025-11-07 | Boyle Dana | Officer | S-Sale | D | Common Stock | 8,342 | 25.16 | 209.9K | 175,996 | D | ↗ |
| 2025-11-05 | Saggar Rajeev | Officer | S-Sale | D | Common Stock | 66,463 | 27.00 | 1.79M | 176,549 | D | ↗ |
| 2025-10-27 | Boyle Dana | Officer | S-Sale | D | Common Stock | 1,073 | 22.93 | 24.6K | 184,338 | D | ↗ |
| 2025-10-27 | Adair Jason | Officer | S-Sale | D | Common Stock | 692 | 22.93 | 15.9K | 174,998 | D | ↗ |
| 2025-10-13 | Schundler Russell | Officer | S-Sale | D | Common Stock | 7,839 | 23.41 | 183.5K | 576,017 | D | ↗ |
| 2025-10-13 | Saggar Rajeev | Officer | S-Sale | D | Common Stock | 5,327 | 23.41 | 124.7K | 247,930 | D | ↗ |
| 2025-10-13 | Moomaw Scott | Officer | S-Sale | D | Common Stock | 4,900 | 23.41 | 114.7K | 153,462 | D | ↗ |
| 2025-10-13 | Krepp Sarah | Officer | S-Sale | D | Common Stock | 1,691 | 23.41 | 39.6K | 141,439 | D | ↗ |
| 2025-10-13 | Kaseta Michael | Officer | S-Sale | D | Common Stock | 11,630 | 23.41 | 272.3K | 352,646 | D | ↗ |
| 2025-10-13 | JEFFS ROGER | Director / Officer | S-Sale | D | Common Stock | 20,261 | 23.41 | 474.3K | 1,032,973 | D | ↗ |
| 2025-10-13 | Boyle Dana | Officer | S-Sale | D | Common Stock | 1,238 | 23.41 | 29.0K | 185,411 | D | ↗ |
| 2025-10-13 | Adair Jason | Officer | S-Sale | D | Common Stock | 3,670 | 23.41 | 85.9K | 175,690 | D | ↗ |
| 2025-10-10 | Schundler Russell | Officer | M-Exempt | D | Performance Stock Units | 3,758 | 0.00 | — | 33,826 | D | ↗ |
| 2025-10-10 | Saggar Rajeev | Officer | M-Exempt | A | Common Stock | 3,530 | 0.00 | — | 253,257 | D | ↗ |
| 2025-10-10 | Moomaw Scott | Officer | M-Exempt | A | Common Stock | 3,108 | 0.00 | — | 158,362 | D | ↗ |
| 2025-10-10 | Kaseta Michael | Officer | M-Exempt | D | Performance Stock Unit | 5,828 | 0.00 | — | 52,453 | D | ↗ |
| 2025-10-10 | JEFFS ROGER | Director / Officer | M-Exempt | A | Common Stock | 13,834 | 0.00 | — | 1,053,234 | D | ↗ |
| 2025-10-10 | Adair Jason | Officer | M-Exempt | D | Restricted Stock Unit | 3,906 | 0.00 | — | 19,531 | D | ↗ |
| 2025-09-15 | SINGH RAMAN | Director | M-Exempt | A | Common Stock | 25,524 | 2.51 | 64.1K | 56,779 | D | ↗ |
| 2025-09-03 | SINGH RAMAN | Director | S-Sale | D | Common Stock | 7,500 | 29.42 | 220.7K | 31,255 | D | ↗ |
| 2025-09-02 | Schundler Russell | Officer | S-Sale | D | Common Stock | 1,063 | 29.05 | 30.9K | 580,098 | D | ↗ |
| 2025-09-02 | Moomaw Scott | Officer | S-Sale | D | Common Stock | 692 | 29.05 | 20.1K | 225,254 | D | ↗ |
| 2025-09-02 | Manning Paul B | Director | S-Sale | D | Common Stock | 74,230 | 29.14 | 2.16M | 430,828 | I | ↗ |
| 2025-09-02 | Kaseta Michael | Officer | S-Sale | D | Common Stock | 1,148 | 29.05 | 33.3K | 358,448 | D | ↗ |
| 2025-09-02 | Adair Jason | Officer | S-Sale | D | Common Stock | 451 | 29.05 | 13.1K | 172,980 | D | ↗ |
| 2025-08-31 | Kaseta Michael | Officer | M-Exempt | D | Restricted Stock Unit | 2,344 | 0.00 | — | 4,687 | D | ↗ |
| 2025-08-29 | Schundler Russell | Officer | M-Exempt | D | Restricted Stock Units | 2,344 | 0.00 | — | 4,687 | D | ↗ |
| 2025-08-29 | Moomaw Scott | Officer | M-Exempt | D | Restricted Stock Units | 1,875 | 0.00 | — | 3,750 | D | ↗ |
| 2025-08-29 | Manning Paul B | Director | S-Sale | D | Common Stock | 188,232 | 27.62 | 5.20M | 759,096 | I | ↗ |
| 2025-08-29 | Krepp Sarah | Officer | S-Sale | D | Common Stock | 209 | 29.05 | 6.1K | 143,130 | D | ↗ |
| 2025-08-29 | Kaseta Michael | Officer | M-Exempt | A | Common Stock | 2,344 | 0.00 | — | 359,596 | D | ↗ |
| 2025-08-29 | Boyle Dana | Officer | S-Sale | D | Common Stock | 296 | 29.05 | 8.6K | 186,649 | D | ↗ |
| 2025-08-29 | Adair Jason | Officer | M-Exempt | A | Common Stock | 1,562 | 0.00 | — | 173,431 | D | ↗ |
| 2025-08-28 | Saggar Rajeev | Officer | S-Sale | D | Common Stock | 20,000 | 27.85 | 557.1K | 249,727 | D | ↗ |
| 2025-08-28 | Manning Paul B | Director | S-Sale | D | Common Stock | 154,337 | 27.94 | 4.31M | 947,328 | I | ↗ |
| 2025-08-28 | Adair Jason | Officer | S-Sale | D | Common Stock | 26,057 | 27.86 | 725.9K | 171,029 | D | ↗ |
| 2025-08-19 | Horobin Joanna | Director | S-Sale | D | Common Stock | 5,000 | 27.17 | 135.9K | 33,755 | D | ↗ |
| 2025-08-15 | Kaseta Michael | Officer | S-Sale | D | Common Stock | 20,000 | 26.18 | 523.7K | 356,412 | D | ↗ |
| 2025-08-05 | Kaseta Michael | Officer | S-Sale | D | Common Stock | 30,000 | 20.00 | 600.1K | 376,412 | D | ↗ |
| 2025-07-28 | Boyle Dana | Officer | S-Sale | D | Common Stock | 1,063 | 19.54 | 20.8K | 186,105 | D | ↗ |
| 2025-07-28 | Adair Jason | Officer | S-Sale | D | Common Stock | 454 | 19.54 | 8.9K | 193,180 | D | ↗ |
| 2025-07-21 | Saggar Rajeev | Officer | S-Sale | D | Common Stock | 2,526 | 14.54 | 36.7K | 268,887 | D | ↗ |
| 2025-07-14 | Schundler Russell | Officer | S-Sale | D | Common Stock | 7,836 | 14.28 | 111.9K | 577,977 | D | ↗ |
| 2025-07-14 | Saggar Rajeev | Officer | S-Sale | D | Common Stock | 5,327 | 14.28 | 76.1K | 271,413 | D | ↗ |
| 2025-07-14 | Moomaw Scott | Officer | S-Sale | D | Common Stock | 4,797 | 14.28 | 68.5K | 223,231 | D | ↗ |
| 2025-07-14 | Krepp Sarah | Officer | S-Sale | D | Common Stock | 2,673 | 14.28 | 38.2K | 142,499 | D | ↗ |
| 2025-07-14 | Kaseta Michael | Officer | S-Sale | D | Common Stock | 11,580 | 14.28 | 165.4K | 406,412 | D | ↗ |
| 2025-07-14 | JEFFS ROGER | Director / Officer | S-Sale | D | Common Stock | 20,252 | 14.28 | 289.2K | 1,038,560 | D | ↗ |
| 2025-07-14 | Boyle Dana | Officer | S-Sale | D | Common Stock | 1,193 | 14.28 | 17.0K | 187,168 | D | ↗ |
| 2025-07-14 | Adair Jason | Officer | S-Sale | D | Common Stock | 2,576 | 14.28 | 36.8K | 193,634 | D | ↗ |
| 2025-07-11 | Schundler Russell | Officer | M-Exempt | D | Performance Stock Units | 3,759 | 0.00 | — | 37,584 | D | ↗ |
| 2025-07-11 | Saggar Rajeev | Officer | M-Exempt | A | Common Stock | 3,531 | 0.00 | — | 276,740 | D | ↗ |
| 2025-07-11 | Moomaw Scott | Officer | M-Exempt | D | Performance Stock Units | 3,107 | 0.00 | — | 31,077 | D | ↗ |
| 2025-07-11 | Kaseta Michael | Officer | M-Exempt | D | Performance Stock Units | 5,828 | 0.00 | — | 58,281 | D | ↗ |
| 2025-07-11 | JEFFS ROGER | Director / Officer | M-Exempt | D | Performance Stock Units | 13,833 | 0.00 | — | 138,336 | D | ↗ |
| 2025-07-11 | Adair Jason | Officer | M-Exempt | D | Performance Stock Units | 2,475 | 0.00 | — | 24,742 | D | ↗ |
| 2025-07-01 | Krepp Sarah | Officer | — | — | Performance Stock Units | 50,861 | 0.00 | — | 0 | D | ↗ |
| 2025-07-01 | Boyle Dana | Officer | — | — | Performance Stock Units | 50,861 | 0.00 | — | 0 | D | ↗ |
| 2025-06-17 | deGoa Damian | Director | A-Award | A | Common Stock | 18,396 | 0.00 | — | 86,471 | D | ↗ |
| 2025-06-17 | SINGH RAMAN | Director | A-Award | A | Common Stock | 18,396 | 0.00 | — | 38,755 | D | ↗ |
| 2025-06-17 | Rielly-Gauvin Katherine | Director | A-Award | A | Common Stock | 18,396 | 0.00 | — | 38,755 | D | ↗ |
| 2025-06-17 | Manning Paul B | Director | A-Award | A | Common Stock | 18,396 | 0.00 | — | 38,755 | D | ↗ |
| 2025-06-17 | Kirsch Arthur S | Director | A-Award | A | Common Stock | 18,396 | 0.00 | — | 40,755 | D | ↗ |
| 2025-06-17 | JOHNSON DAVID EDWARD | Director / 10% Owner | A-Award | A | Common Stock, $0.001 par value per share ("Common Stock") | 18,396 | 0.00 | — | 38,755 | D | ↗ |
| 2025-06-17 | Horobin Joanna | Director | A-Award | A | Common Stock | 18,396 | 0.00 | — | 38,755 | D | ↗ |
| 2025-06-17 | Bloch Stephen M | Director | A-Award | A | Common Stock | 18,396 | 0.00 | — | 38,755 | D | ↗ |
| 2025-06-04 | Schundler Russell | Officer | S-Sale | D | Common Stock | 8,460 | 16.97 | 143.6K | 582,054 | D | ↗ |
| 2025-06-04 | Saggar Rajeev | Officer | S-Sale | D | Common Stock | 7,597 | 16.97 | 128.9K | 273,209 | D | ↗ |
| 2025-06-04 | Moomaw Scott | Officer | S-Sale | D | Common Stock | 6,656 | 16.97 | 113.0K | 224,921 | D | ↗ |
| 2025-06-04 | Kaseta Michael | Officer | S-Sale | D | Common Stock | 14,777 | 16.97 | 250.8K | 412,164 | D | ↗ |
| 2025-06-04 | JEFFS ROGER | Director / Officer | S-Sale | D | Common Stock | 30,610 | 16.97 | 519.5K | 1,044,979 | D | ↗ |
| 2025-06-04 | Adair Jason | Officer | S-Sale | D | Common Stock | 3,597 | 16.97 | 61.0K | 193,735 | D | ↗ |
| 2025-06-03 | Schundler Russell | Officer | M-Exempt | D | Performance Stock Units | 18,792 | 0.00 | — | 41,343 | D | ↗ |
| 2025-06-03 | Saggar Rajeev | Officer | M-Exempt | A | Common Stock | 17,654 | 0.00 | — | 280,806 | D | ↗ |
| 2025-06-03 | Moomaw Scott | Officer | M-Exempt | D | Performance Stock Units | 15,539 | 0.00 | — | 34,184 | D | ↗ |
| 2025-06-03 | Kaseta Michael | Officer | M-Exempt | D | Performance Stock Units | 29,141 | 0.00 | — | 64,109 | D | ↗ |
| 2025-06-03 | JEFFS ROGER | Director / Officer | M-Exempt | A | Common Stock | 69,169 | 0.00 | — | 1,075,589 | D | ↗ |
| 2025-06-03 | Adair Jason | Officer | M-Exempt | A | Common Stock | 12,371 | 0.00 | — | 197,332 | D | ↗ |
| 2025-06-02 | Schundler Russell | Officer | S-Sale | D | Common Stock | 923 | 16.74 | 15.5K | 571,722 | D | ↗ |
| 2025-06-02 | Moomaw Scott | Officer | S-Sale | D | Common Stock | 581 | 16.74 | 9.7K | 216,038 | D | ↗ |
| 2025-06-02 | Kaseta Michael | Officer | S-Sale | D | Common Stock | 859 | 16.74 | 14.4K | 397,800 | D | ↗ |
| 2025-06-02 | Adair Jason | Officer | S-Sale | D | Common Stock | 451 | 16.74 | 7.5K | 184,961 | D | ↗ |
| 2025-05-30 | Schundler Russell | Officer | M-Exempt | A | Common Stock | 2,344 | 0.00 | — | 572,645 | D | ↗ |
| 2025-05-30 | Moomaw Scott | Officer | M-Exempt | D | Restricted Stock Unit | 1,875 | 0.00 | — | 5,625 | D | ↗ |
| 2025-05-30 | Kaseta Michael | Officer | M-Exempt | A | Common Stock | 2,344 | 0.00 | — | 398,659 | D | ↗ |
| 2025-05-30 | Adair Jason | Officer | M-Exempt | D | Restricted Stock Unit | 1,563 | 0.00 | — | 4,687 | D | ↗ |
| 2025-04-28 | Adair Jason | Officer | S-Sale | D | Common Stock | 455 | 14.24 | 6.5K | 183,849 | D | ↗ |
| 2025-04-21 | Saggar Rajeev | Officer | S-Sale | D | Common Stock | 2,450 | 13.67 | 33.5K | 263,152 | D | ↗ |
| 2025-04-15 | Moomaw Scott | Officer | S-Sale | D | Common Stock | 3,406 | 13.57 | 46.2K | 214,744 | D | ↗ |
| 2025-04-14 | Schundler Russell | Officer | S-Sale | D | Common Stock | 5,964 | 13.57 | 80.9K | 570,301 | D | ↗ |
| 2025-04-14 | Saggar Rajeev | Officer | S-Sale | D | Common Stock | 3,714 | 13.57 | 50.4K | 265,602 | D | ↗ |
| 2025-04-14 | Kaseta Michael | Officer | S-Sale | D | Common Stock | 8,283 | 13.57 | 112.4K | 396,315 | D | ↗ |
| 2025-04-14 | JEFFS ROGER | Director / Officer | S-Sale | D | Common Stock | 14,130 | 13.57 | 191.7K | 1,006,420 | D | ↗ |
| 2025-04-14 | Adair Jason | Officer | S-Sale | D | Common Stock | 1,856 | 13.57 | 25.2K | 184,304 | D | ↗ |
| 2025-04-11 | Adair Jason | Officer | M-Exempt | D | Restricted Stock Unit | 3,906 | 0.00 | — | 27,344 | D | ↗ |
| 2025-03-03 | Schundler Russell | Officer | S-Sale | D | Common Stock | 930 | 15.45 | 14.4K | 576,265 | D | ↗ |
| 2025-03-03 | Moomaw Scott | Officer | S-Sale | D | Common Stock | 592 | 15.45 | 9.1K | 218,150 | D | ↗ |
| 2025-03-03 | Kaseta Michael | Officer | S-Sale | D | Common Stock | 874 | 15.45 | 13.5K | 404,598 | D | ↗ |
| 2025-03-03 | Adair Jason | Officer | S-Sale | D | Common Stock | 451 | 15.45 | 7.0K | 182,254 | D | ↗ |
| 2025-02-28 | Schundler Russell | Officer | M-Exempt | A | Common Stock | 2,344 | 0.00 | — | 577,195 | D | ↗ |
| 2025-02-28 | Moomaw Scott | Officer | M-Exempt | A | Common Stock | 1,875 | 0.00 | — | 218,742 | D | ↗ |
| 2025-02-28 | Kaseta Michael | Officer | M-Exempt | A | Common Stock | 2,344 | 0.00 | — | 405,472 | D | ↗ |
| 2025-02-28 | Adair Jason | Officer | M-Exempt | A | Common Stock | 1,562 | 0.00 | — | 182,705 | D | ↗ |
| 2025-02-22 | Boyle Dana | Officer | — | — | Stock Option (Right to Buy) | 50,000 | 3.44 | 172.0K | 0 | D | ↗ |
| 2025-01-27 | Adair Jason | Officer | S-Sale | D | Common Stock | 445 | 14.20 | 6.3K | 179,770 | D | ↗ |
| 2025-01-21 | Saggar Rajeev | Officer | S-Sale | D | Common Stock | 2,445 | 13.00 | 31.8K | 267,943 | D | ↗ |
| 2025-01-14 | Schundler Russell | Officer | S-Sale | D | Common Stock | 16,393 | 11.78 | 193.1K | 573,478 | D | ↗ |
| 2025-01-14 | Saggar Rajeev | Officer | S-Sale | D | Common Stock | 6,249 | 11.78 | 73.6K | 270,388 | D | ↗ |
| 2025-01-14 | Moomaw Scott | Officer | S-Sale | D | Common Stock | 8,362 | 11.78 | 98.5K | 215,494 | D | ↗ |
| 2025-01-14 | Kaseta Michael | Officer | S-Sale | D | Common Stock | 23,370 | 11.78 | 275.3K | 401,755 | D | ↗ |
| 2025-01-14 | JEFFS ROGER | Director / Officer | S-Sale | D | Common Stock | 22,343 | 11.78 | 263.2K | 1,019,177 | D | ↗ |
| 2025-01-14 | Adair Jason | Officer | S-Sale | D | Common Stock | 4,809 | 11.78 | 56.7K | 180,215 | D | ↗ |
| 2025-01-11 | Schundler Russell | Officer | A-Award | A | Performance Stock Units | 102,543 | 0.00 | — | 102,543 | D | ↗ |
| 2025-01-11 | Saggar Rajeev | Officer | A-Award | A | Common Stock | 71,780 | 0.00 | — | 276,637 | D | ↗ |
Executive team
Top executives
EBIT / Employee
-302.2K
Shares Outstanding
88.11M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Roger A. Jeffs, Ph.D. Chief Executive Officer | 824.0K | 25.0K | 5.59M | — | 1.25M | 18.3K | 7.71M | 72.49% | ↗ |
| 2 | 2025 | Michael Kaseta Chief Financial Officer and Chief Operating Officer | 592.3K | 25.0K | 2.75M | — | 772.8K | 16.0K | 4.16M | 66.17% | ↗ |
| 3 | 2025 | Russell Schundler General Counsel and Secretary | 540.8K | 25.0K | 2.50M | — | 588.0K | 17.3K | 3.67M | 68.10% | ↗ |
| 4 | 2025 | Rajeev Saggar, M.D. Chief Medical Officer | 539.3K | 25.0K | 1.75M | — | 586.5K | 16.0K | 2.92M | 60.00% | ↗ |
| 5 | 2025 | Scott Moomaw Chief Commercial Officer | 449.9K | 25.0K | 1.70M | — | 489.2K | 16.8K | 2.68M | 63.41% | ↗ |
| 6 | 2024 | Roger Jeffs, Ph.D. Chief Executive Officer | 800.0K | — | 5.53M | — | 403.2K | 14.6K | 6.75M | 81.96% | ↗ |
| 7 | 2024 | Roger A. Jeffs, Ph.D. Chief Executive Officer | 800.0K | — | 5.53M | — | 403.2K | 14.6K | 6.75M | 81.96% | ↗ |
| 8 | 2024 | Michael Kaseta Chief Financial Officer and Chief Operating Officer | 573.0K | — | 2.95M | — | 248.4K | 14.6K | 3.79M | 77.94% | ↗ |
| 9 | 2024 | Russell Schundler General Counsel and Secretary | 525.0K | — | 2.13M | — | 189.0K | 15.8K | 2.86M | 74.47% | ↗ |
| 10 | 2024 | Rajeev Saggar, M.D. Chief Medical Officer | 523.6K | — | 1.41M | — | 188.5K | 14.9K | 2.14M | 66.02% | ↗ |
| 11 | 2024 | Scott Moomaw Chief Commercial Officer | 436.8K | — | 1.24M | — | 157.2K | 14.6K | 1.85M | 67.13% | ↗ |
| 12 | 2023 | Roger Jeffs, Ph.D. Chief Executive Officer | 689.0K | — | 1.79M | 1.78M | 620.1K | 14.0K | 4.89M | 72.94% | ↗ |
| 13 | 2023 | Roger A. Jeffs, Ph.D. Chief Executive Officer | 689.0K | — | 1.79M | 1.78M | 620.1K | 14.0K | 4.89M | 72.94% | ↗ |
| 14 | 2023 | Michael Kaseta Chief Financial Officer and Chief Operating Officer | 501.1K | — | 769.2K | 766.6K | 375.8K | 14.0K | 2.43M | 63.29% | ↗ |
| 15 | 2023 | Russell Schundler General Counsel and Secretary | 477.0K | — | 642.7K | 640.5K | 286.2K | 15.3K | 2.06M | 62.24% | ↗ |
| 16 | 2023 | Rajeev Saggar, M.D. Chief Medical Officer | 503.5K | — | 514.2K | 512.4K | 302.1K | 15.0K | 1.85M | 55.58% | ↗ |
| 17 | 2023 | Scott Moomaw Chief Commercial Officer | 420.0K | — | 514.2K | 512.4K | 252.0K | 14.2K | 1.71M | 59.94% | ↗ |
| 18 | 2022 | Roger Jeffs, Ph.D. Chief Executive Officer | 325.0K | 65.0K | 325.0K | 9.90M | 130.0K | 12.2K | 10.76M | 95.05% | ↗ |
| 19 | 2022 | Michael Kaseta Chief Financial Officer and Chief Operating Officer | 472.7K | 66.2K | 234.4K | 944.6K | 75.6K | 13.3K | 1.81M | 65.25% | ↗ |
| 20 | 2022 | Michael Kaseta Chief Financial Officer | 472.7K | 12.00 | 234.4K | 944.6K | 75.6K | 13.3K | 1.81M | 65.25% | ↗ |
| 21 | 2022 | Russell Schundler General Counsel and Secretary | 394.7K | 63.0K | 234.4K | 944.6K | 72.0K | 12.2K | 1.72M | 68.51% | ↗ |
| 22 | 2022 | Damian deGoa Former Chief Executive Officer | 45.3K | — | — | — | — | 1.9K | 121.0K | 0.00% | ↗ |
| 23 | 2021 | Tushar Shah, M.D. Chief Medical Officer, Head of R&D | 456.7K | 70.0K | 152.2K | 247.4K | 252.1K | 13.6K | 1.19M | 33.53% | ↗ |
| 24 | 2021 | Robert A. Lippe Chief Operations Officer | 454.5K | 10.0K | 152.2K | 247.4K | 250.9K | 13.4K | 1.13M | 35.42% | ↗ |
| 25 | 2021 | Damian deGoa Former Chief Executive Officer | 561.3K | 10.0K | — | 19.0K | — | 13.00 | 988.4K | 1.93% | ↗ |
| 26 | 2021 | Michael Kaseta Chief Financial Officer | 456.7K | 140.0K | 27.5K | 60.3K | 252.1K | 16.4K | 952.9K | 9.21% | ↗ |
| 27 | 2021 | Russell Schundler General Counsel and Secretary | 253.7K | 10.0K | — | 386.9K | 164.8K | 9.3K | 824.8K | 46.91% | ↗ |
| 28 | 2020 | Damian deGoa Chief Executive Officer | 20.2K | — | — | 4.51M | — | — | 4.53M | 99.55% | ↗ |
| 29 | 2020 | Damian deGoa Former Chief Executive Officer | 20.2K | — | — | 4.51M | — | — | 4.53M | 99.55% | ↗ |
| 30 | 2020 | Tushar Shah, M.D. Chief Medical Officer, Head of R&D | 276.1K | 25.0K | — | 1.33M | 58.7K | 240.00 | 1.69M | 78.66% | ↗ |
| 31 | 2020 | Neal F. Fowler Former Chief Executive Officer | 541.9K | — | 100.6K | 291.3K | — | 15.5K | 1.08M | 36.21% | ↗ |
| 32 | 2020 | Robert A. Lippe Chief Operations Officer | 447.8K | — | 35.9K | 103.8K | 86.6K | 13.4K | 688.8K | 20.28% | ↗ |
| 33 | 2020 | Richard D. Katz, M.D. Former Chief Financial Officer | 253.0K | — | 35.9K | 103.8K | — | 153.0K | 546.0K | 25.58% | ↗ |
| 34 | 2019 | Neal F. Fowler Former Chief Executive Officer | 508.2K | — | — | 966.7K | 241.7K | 12.4K | 1.73M | 55.91% | ↗ |
| 35 | 2019 | Richard D. Katz, M.D. Former Chief Financial Officer | 217.7K | — | — | 1.11M | 93.7K | 9.7K | 1.43M | 77.59% | ↗ |
| 36 | 2019 | Robert A. Lippe Chief Operations Officer | 421.3K | — | — | 360.6K | 160.2K | 12.3K | 954.4K | 37.79% | ↗ |
CEO compensation breakdown
Proxy statements
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Roger A. Jeffs | Chief Executive Officer & Director | 2M | — |
| Michael Kaseta | Chief Operating Officer & Chief Financial Officer | 1M | male |
| Russell Schundler | General Counsel & Corporate Secretary | 1M | male |
| Rajeev Saggar | Chief Medical Officer | 1M | — |
| Scott Moomaw | Chief Commercial Officer | 981.0K | male |
| Harold Alterson | Senior Vice President of Quality | — | male |
| Jason Adair | Chief Business Officer | — | male |
| Matt Snow | Senior Vice President of Sales | — | — |
| Beth-Anne Lang | Senior Vice President of Global Regulatory Affairs | — | female |
| Michael Post | Senior Vice President of Marketing | — | male |
| Sarah Krepp SPHR | Chief Human Resources Officer | — | female |
| Michael Hunter | Senior Vice President of Manufacturing Operations | — | male |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for LQDA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
